Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03580811 · ClinicalTrials.gov registry record · NA
Clinical Effects of Hard and Soft Tissue Grafting With Dental Implants
A NA study, sponsored by University of Louisville.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT03580811: Completed NA study, sponsored by University of Louisville.
NCT03580811 is a NA study that has completed, run by University of Louisville. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03580811, a NA study, has completed, sponsored by University of Louisville.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The study will be done to see if Implant placement and simultaneous grafting using alloderm alone will result in the same facial ridge contour and soft tissue thickness as alloderm plus bovine derived xenograft. Is the facial soft tissue contour and thickness for alloderm plus bovine derived xenograft is significantly increased compared to alloderm alone.
Primary Outcome
Contour will be categorized as concave,flat or convex(subjective categories).
Interventions
- DEVICE Dental Implant &ADMG
- DEVICE Dental implant & ADMG & BDX
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2018-12-04 |
| Est. Completion | 2021-04-30 |
| Phase | NA |
What the finished NCT03580811 record still lists
NCT03580811 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Dental Implant &ADMG is the first listed.
NCT03580811 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03580811 about?
NCT03580811 is a clinical study titled "Clinical Effects of Hard and Soft Tissue Grafting With Dental Implants". The study will be done to see if Implant placement and simultaneous grafting using alloderm alone will result in the same facial ridge contour and soft tissue thickness as alloderm plus bovine derived xenograft. Is the facial soft tissue contour and thickness for alloderm plus bovine derived xenogra...
What is the current status of trial NCT03580811?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2018-12-04. Estimated completion is 2021-04-30.
What interventions are being tested in trial NCT03580811?
The interventions under investigation include: Dental Implant &ADMG (DEVICE), Dental implant & ADMG & BDX (DEVICE).
Who is sponsoring clinical trial NCT03580811?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03580811's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI